Union Chemicals Lanka PLC (COSE:UCAR.N0000)
890.00
-1.00 (-0.11%)
At close: Jul 30, 2025
Checkpoint Therapeutics Balance Sheet
Financials in millions LKR. Fiscal year is January - December.
Millions LKR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 25, 2025 | Dec '24 Dec 25, 2024 | Dec '23 Dec 25, 2023 | Dec '22 Dec 25, 2022 | Dec '21 Dec 25, 2021 | Dec '20 Dec 25, 2020 | 2016 - 2020 |
Cash & Equivalents | 106.17 | 71.38 | 87.54 | 71.46 | 76.62 | 57.87 | Upgrade |
Short-Term Investments | - | - | - | - | 3.54 | - | Upgrade |
Cash & Short-Term Investments | 106.17 | 71.38 | 87.54 | 71.46 | 80.16 | 57.87 | Upgrade |
Cash Growth | 93.55% | -18.46% | 22.50% | -10.86% | 38.51% | 537.92% | Upgrade |
Accounts Receivable | 304.12 | 211.8 | 165.05 | 124.25 | 344.28 | 223.77 | Upgrade |
Other Receivables | - | 29.42 | 23.49 | 33.11 | 16.57 | 4.88 | Upgrade |
Receivables | 304.12 | 242.39 | 189.6 | 158.29 | 361.69 | 229.51 | Upgrade |
Inventory | 450.33 | 412.9 | 505.79 | 688.68 | 345.45 | 201.48 | Upgrade |
Other Current Assets | 343.99 | 368.54 | 137.53 | 55.34 | 16.78 | 11.62 | Upgrade |
Total Current Assets | 1,205 | 1,095 | 920.46 | 973.77 | 804.08 | 500.49 | Upgrade |
Property, Plant & Equipment | 268.87 | 264.48 | 270.65 | 244.23 | 341.67 | 301.19 | Upgrade |
Long-Term Investments | 40 | 40 | 45 | 45 | - | - | Upgrade |
Other Long-Term Assets | 74.93 | 75.71 | 78.13 | 81.88 | 6.08 | 8.15 | Upgrade |
Total Assets | 1,589 | 1,476 | 1,314 | 1,345 | 1,152 | 810.28 | Upgrade |
Accounts Payable | 149.26 | 47.14 | 61.42 | 201.71 | 192.96 | 33.61 | Upgrade |
Accrued Expenses | - | 58.35 | 44.88 | 26.49 | 27.09 | 20.37 | Upgrade |
Short-Term Debt | - | 0.11 | 4.42 | 138.77 | 39.02 | 30.62 | Upgrade |
Current Portion of Long-Term Debt | - | - | - | - | 48.77 | - | Upgrade |
Current Income Taxes Payable | 56.14 | 49.41 | 48.07 | 26.69 | 28.67 | 24.23 | Upgrade |
Other Current Liabilities | 12.55 | 12.62 | 7.58 | 12.27 | 6.37 | 10.46 | Upgrade |
Total Current Liabilities | 217.95 | 167.62 | 166.37 | 405.94 | 342.87 | 119.28 | Upgrade |
Long-Term Debt | - | - | - | - | 2.69 | 7.04 | Upgrade |
Long-Term Deferred Tax Liabilities | 15.85 | 15.85 | 17.5 | 11.51 | 5.46 | 3.21 | Upgrade |
Total Liabilities | 259.9 | 208.9 | 203.93 | 436.67 | 367.23 | 151.37 | Upgrade |
Common Stock | 15 | 15 | 15 | 15 | 15 | 15 | Upgrade |
Retained Earnings | 1,314 | 1,252 | 1,096 | 893.61 | 769.89 | 643.91 | Upgrade |
Shareholders' Equity | 1,329 | 1,267 | 1,111 | 908.61 | 784.89 | 658.91 | Upgrade |
Total Liabilities & Equity | 1,589 | 1,476 | 1,314 | 1,345 | 1,152 | 810.28 | Upgrade |
Total Debt | - | 0.11 | 4.42 | 138.77 | 90.48 | 37.67 | Upgrade |
Net Cash (Debt) | 106.17 | 71.27 | 83.12 | -67.31 | -10.32 | 20.21 | Upgrade |
Net Cash Growth | 93.55% | -14.26% | - | - | - | - | Upgrade |
Net Cash Per Share | 70.78 | 47.51 | 55.41 | -44.87 | -6.88 | 13.47 | Upgrade |
Filing Date Shares Outstanding | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | Upgrade |
Total Common Shares Outstanding | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | Upgrade |
Working Capital | 986.67 | 927.58 | 754.1 | 567.84 | 461.21 | 381.2 | Upgrade |
Book Value Per Share | 885.97 | 844.75 | 740.38 | 605.74 | 523.26 | 439.27 | Upgrade |
Tangible Book Value | 1,329 | 1,267 | 1,111 | 908.61 | 784.89 | 658.91 | Upgrade |
Tangible Book Value Per Share | 885.97 | 844.75 | 740.38 | 605.74 | 523.26 | 439.27 | Upgrade |
Land | - | 110.38 | 110.38 | 110.38 | 110.38 | 78.98 | Upgrade |
Buildings | - | 67.35 | 65.24 | 50.66 | 132.58 | 129.41 | Upgrade |
Machinery | - | 272.77 | 265.43 | 237.75 | 235.41 | 214.01 | Upgrade |
Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.